PRMT5 is a prognostic-related biomarker associated with the tumor immune microenvironment in lung adenocarcinoma.
- DOI
- 10.1007/s12094-026-04436-z
- Published
- 2026 Jun 5
- Container
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12094-026-04436-z,
title = {PRMT5 is a prognostic-related biomarker associated with the tumor immune microenvironment in lung adenocarcinoma.},
author = {Xia X and Zhou X and Zhang Y and Chen C and Ji X and Huang L and He Z and Huang D and Wang J and Hou J},
year = {2026},
journal = {Clinical \& translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
doi = {10.1007/s12094-026-04436-z},
url = {https://doi.org/10.1007/s12094-026-04436-z}
}RIS
TY - JOUR TI - PRMT5 is a prognostic-related biomarker associated with the tumor immune microenvironment in lung adenocarcinoma. AU - Xia X AU - Zhou X AU - Zhang Y AU - Chen C AU - Ji X AU - Huang L AU - He Z AU - Huang D AU - Wang J AU - Hou J PY - 2026 JO - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico DO - 10.1007/s12094-026-04436-z UR - https://doi.org/10.1007/s12094-026-04436-z ER -
APA
X, X., X, Z., Y, Z., C, C., X, J., L, H., Z, H., D, H., J, W., & J, H. (2026). PRMT5 is a prognostic-related biomarker associated with the tumor immune microenvironment in lung adenocarcinoma.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04436-z
Source records
- pubmed · retrieved 2026-09-27T16:47:44.349Z